Abstract
Abstract
Background
The “Primary Immunodeficiencies (PIDs) principles of care” were published in 2014 as the gold standard for care of patients with PIDs, setting a common goal for stakeholders to ensure that patients with PID have access to appropriate care and good quality of life. Since then, IPOPI (the International Patient Organisation for Primary Immunodeficiencies), has been working with national PID patient organisations as well as collaborating with scientific and medical institutions and experts to bring these principles closer to the day-to-day life of individuals with PIDs.
Method
The six PID Principles of Care were revised to consider advances in the field, as well as political developments that had occurred after their initial publication in 2014. Based on this revision the list was updated, and a new principle was added. The six established principles were: diagnosis, treatment, universal health coverage, specialised centres, national patient organisations and registries. Each principle was structured and measured through a series of criteria, and was given the same weight, as they have been considered to all be equally important. Specific weights were attributed to the criteria depending on their relevance and importance to quantify the principle. The index was translated into a survey for data collection: initially involving data from selected countries for a pilot, followed by integration of data from IPOPI’s national member organisations and key countries.
Results
The PID Life Index was developed in 2020 to assess the status of the PID environment and the implementation of the 6 principles worldwide. The Index allows for benchmarking countries either according to a set of principles and criteria or based on the user’s preferences. This can be displayed in an interactive map or through a data visualisation system.
Conclusion
The PID Life Index has been developed successfully and has potential to become an important source of information for PID stakeholders, to increase awareness and information as well as support advocacy initiatives on PIDs nationally, regionally or globally.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Genetics (clinical),General Medicine
Reference8 articles.
1. Meyts I, Bousfiha A, Duff C, Singh S, Lau Y, Condino-Neto A, et al. Primary immunodeficiencies: a decade of progress and a promising future. Front Immunol. 2021. https://doi.org/10.3389/fimmu.2020.625753.
2. Bousfiha A, Jeddane L, Picard C, Al-Herz W, Ailal F, Chatila T, et al. Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification. J Clin Immunol. 2020;40(1):66–81. https://doi.org/10.1007/s10875-020-00758-x.
3. Chapel H, Prevot J, Gaspar HB, Español T, Bonilla FA, Solis L, et al. Primary immune deficiencies—principles of care. Front Immunol. 2014. https://doi.org/10.3389/fimmu.2014.00627.
4. European Commission. Implementation report on the Commission Communication on Rare Diseases: Europe’s challenges and Council Recommendation of 8 June 2009 on an action in the field of rare diseases. COM (2014) 548 final (2014). https://ec.europa.eu/health/sites/default/files/rare_diseases/docs/2014_rarediseases_implementationreport_en.pdf.
5. United Nations General Assembly. Political declaration of the high-level meeting on universal health coverage. Resolution adopted by the General Assembly on 10 October 2019. Resolution 74/2 (2019). https://undocs.org/en/A/RES/74/2.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献